Identifying adipocyte-derived exosomal miRNAs as potential novel prognostic markers for radiotherapy of esophageal squamous cell carcinoma

doi:10.4251/wjgo.v17.i2.98808

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (510)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

HTML

291

Figures (1-7)

Tables (1-3)

Sum=433

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=44

Feb 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 98808
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98808

Full Size Figure Download Figure

Figure 3 Characterization of extracted exosomes. A: Transmission electron microscopy image of exosomes (scale bar = 100 nm); B: Nanoparticle tracking analysis of exosome concentration and size; C: Western blot detection of exosomal-specific markers TSG101 and CD9; D: Uptake of exosomes by KYSE30 cells.

Citation: Ge YY, Xia XC, Wu AQ, Ma CY, Yu LH, Zhou JY. Identifying adipocyte-derived exosomal miRNAs as potential novel prognostic markers for radiotherapy of esophageal squamous cell carcinoma. World J Gastrointest Oncol 2025; 17(2): 98808
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/98808.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.98808